Table 3 Proportion of prescribed antibiotics (ATC level 5) by indication
From: Antibiotic use in a tertiary healthcare facility in Ghana: a point prevalence survey
Drug name (generic) | Total, % | Community acquired | Hospital acquired | Surgical prophylaxis | Medical prophylaxis |
|---|---|---|---|---|---|
| Â | n, % | n, % | n, % | n, % | |
Metronidazole | 107 (17.5) | 22 (9.0) | 16 (12.5) | 66 (32.2) | 3 (9.1) |
Amoxicillin- clavulanic acid | 82 (13.4) | 18 (7.4) | 9 (7.0) | 53 (25.9) | 2 (13.4) |
Ceftriaxone | 74 (12.1) | 44 (18.0) | 16 (12.5) | 13 (6.3) | 1 (3.0) |
Cefuroxime | 61 (10.0) | 24 (9.8) | 7 (5.5) | 28 (13.7) | 2 (6.1) |
Cloxacillin | 52 (8.5) | 26 (10.6) | 15 (11.7) | 8 (3.9) | 3 (9.1) |
Clindamycin | 49 (8.0) | 21 (8.6) | 13 (10.2) | 15 (7.3 | – |
Gentamicin | 46 (7.5) | 26 (10.6) | 13 (10.2) | 5 (2.4) | 2 (6.1) |
Ciprofloxaciin | 39 (6.4) | 17 (6.9) | 14 (10.9) | 8 (3.9) | – |
Azithromycin | 21 (3.4) | 16 (6.5) | 3 (2.3) | 2 (1.0) | – |
Co-trimoxazole | 14 (2.3) | 3 (1.2) | 1 (0.8) | – | 10 (30.3) |
Meropenem | 12 (2.0) | 2 (0.8) | 9 (7.0) | 1 (0.5) | – |
Amikacin | 8 (1.3) | 3 (1.2) | 3 (2.3) | – | 2 (6.1) |
Ampicillin | 10 (1.6) | 7 (2.9) | – | 2 (1.0) | 1 (3.0) |
Crystal penicillin | 7 (1.2) | 2 (0.8) | 2 (1.6) | – | 3 (9.1) |
Cefotaxime | 6 (1.0) | 5 (2.0) | 1 (0.8) | – | – |
Levofloxacin | 5 (0.8) | 1 (0.4) | 3 (2.3) | 1 (0.5) | – |
Erythromycin | 5 (0.8) | 2 (0.8) | – | – | 3 (9.1) |
Clarithromycin | 3 (0.5) | 2 (0.8) | – | 1 (0.5) | – |
Nitrofuratoin | 2 (0.3) | – | 1 (0.8) | 1 (0.5) | – |
Ceftazidine | 2 (0.3) | – | 2 (1.6) | – | – |
Amoxicillin | 1 (0.2) | 1 (0.4) | – | – | – |
Cefixime | 1 (0.2) | – | – | 1 (0.5) | – |
Doxycycline | 1 (0.2) | 1 (0.4) | – | – | – |
Cefpodoxime | 1 (0.2) | – | 1 (0.8) | – | – |
Nalidixic acid | 1 (0.2) | 1 (0.4) | – | – | – |
Vancomycin | 1 (0.2) | 1 (0.4) | – | – | – |
Total | 611(100) | 245 | 128 | 205 | 33 |